These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 6136545

  • 41. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
    Sabapathy TK, Cheng Q, Hui KM.
    Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
    [Abstract] [Full Text] [Related]

  • 42. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR, Nowinski RC, Henney CS.
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract] [Full Text] [Related]

  • 43. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
    Louis JA, Moedder E, MacDonald HR, Engers HD.
    J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
    [Abstract] [Full Text] [Related]

  • 44. A monoclonal antibody detecting unusual Thy-1 determinants.
    Auchincloss H, Ozato K, Sachs DH.
    J Immunol; 1982 Apr; 128(4):1584-9. PubMed ID: 6174608
    [Abstract] [Full Text] [Related]

  • 45. Generation of H-2-reactive T cell lines that bear the 5936 idiotype(s).
    Rubin B, Golstein P, Nordfang O, Hertel-Wulff B.
    J Immunol; 1980 Jan; 124(1):161-7. PubMed ID: 6153092
    [Abstract] [Full Text] [Related]

  • 46. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC, Paul RD, Lopez DM.
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [Abstract] [Full Text] [Related]

  • 47. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
    Moser G, Burakoff SJ, Abbas AK.
    J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
    [Abstract] [Full Text] [Related]

  • 48. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
    Karlhofer FM, Hunziker R, Reichlin A, Margulies DH, Yokoyama WM.
    J Immunol; 1994 Sep 15; 153(6):2407-16. PubMed ID: 8077656
    [Abstract] [Full Text] [Related]

  • 49. I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively.
    Lorber MI, Loken MR, Stall AM, Fitch FW.
    J Immunol; 1982 Jun 15; 128(6):2798-803. PubMed ID: 6804568
    [Abstract] [Full Text] [Related]

  • 50. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR.
    J Immunol; 1980 Dec 15; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract] [Full Text] [Related]

  • 51. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
    Shain B, Holt CA, Lilly F.
    J Immunol; 1982 Aug 15; 129(2):722-9. PubMed ID: 6177779
    [Abstract] [Full Text] [Related]

  • 52. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ, Levy RB, Shearer GM.
    J Immunol; 1981 Apr 15; 126(4):1255-9. PubMed ID: 6970767
    [Abstract] [Full Text] [Related]

  • 53. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF.
    Bone Marrow Transplant; 1994 Mar 15; 13(3):293-301. PubMed ID: 8199571
    [Abstract] [Full Text] [Related]

  • 54. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
    Nio Y, Hirahara N, Minari Y, Iguchi C, Yamasawa K, Toga T, Tamura K.
    Anticancer Res; 2000 Mar 15; 20(5A):3293-9. PubMed ID: 11062756
    [Abstract] [Full Text] [Related]

  • 55. Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras.
    Sharrow SO, Mathieson BJ, Singer A.
    J Immunol; 1981 Apr 15; 126(4):1327-35. PubMed ID: 6162887
    [Abstract] [Full Text] [Related]

  • 56. Peripheral CD4+ T cell maturation recognized by increased expression of Thy-1/CD90 bearing the 6C10 carbohydrate epitope.
    Gui M, Wiest DL, Li J, Kappes D, Hardy RR, Hayakawa K.
    J Immunol; 1999 Nov 01; 163(9):4796-804. PubMed ID: 10528179
    [Abstract] [Full Text] [Related]

  • 57. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J, Yon RW, Chavin KD, Qin L, Woodward J, Ding Y, Yagita H, Bromberg JS.
    Transplantation; 1995 Apr 27; 59(8):1162-71. PubMed ID: 7537394
    [Abstract] [Full Text] [Related]

  • 58. Expression of proliferation and differentiation antigens in response to modulation of membrane fluidity in chronic lymphocytic leukemia lymphocytes.
    Daefler S, Krueger GR.
    Anticancer Res; 1989 Apr 27; 9(2):501-6. PubMed ID: 2751273
    [Abstract] [Full Text] [Related]

  • 59. [Changes in the expression of the surface antigens of thymocytes during their cultivation with macrophages].
    Anfalova TV, Galaktionov VG, Khromykh LM, Kapinus LN.
    Ontogenez; 1989 Apr 27; 20(3):294-9. PubMed ID: 2570390
    [Abstract] [Full Text] [Related]

  • 60. Transmission of maternal blood cells to the fetus during pregnancy: detection in mouse neonatal spleen by immunofluorescence flow cytometry and polymerase chain reaction.
    Shimamura M, Ohta S, Suzuki R, Yamazaki K.
    Blood; 1994 Feb 15; 83(4):926-30. PubMed ID: 7906566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.